echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > Tohoku Pharmaceutical: Dapoxetine hydrochloride, the raw material, passed CDE approval

    Tohoku Pharmaceutical: Dapoxetine hydrochloride, the raw material, passed CDE approval

    • Last Update: 2021-09-20
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

    On August 26, Northeast Pharmaceutical issued an announcement stating that the company had recently inquired and learned on the platform of the “Registration Information Disclosure of APIs, Pharmaceutical Excipients and Packaging Materials” of the State Food and Drug Administration, and learned that the “Dapoxetine Hydrochloride” API registration application was passed Approved by CDE


    Dapoxetine hydrochloride is a selective serotonin reuptake inhibitor (SSRIs) drug, mainly suitable for the treatment of premature ejaculation (PE) patients aged 18 to 64 years old


    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.